Enhanced attenuation of nicotine discrimination in rats by combining nicotine-specific antibodies with a nicotinic receptor antagonist

Pharmacology Biochemistry and Behavior

Volumn 102, Issue 1, 2012, Pages 157-162

  Lesage, Mark G ^a,b   Shelley, David ^a   Pravetoni, Marco ^a,b   Pentel, Paul R ^a,b,c  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Drug discrimination; Mecamylamine; Monoclonal nicotine specific antibodies; Nicotine; Rat

Indexed keywords

MECAMYLAMINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY NIC311; NICOTINE TARTRATE; NICOTINIC RECEPTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; MALE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; CONDITIONING, OPERANT; DISCRIMINATION LEARNING; MALE; NICOTINE; NICOTINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; UP-REGULATION;

ANIMALIA; NICOTIANA TABACUM; RATTUS;

EID: 84860335932     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.03.026     Document Type: Article

References (44)

1. N.L. Benowitz, J. Hukkanen, and P. Jacob Nicotine chemistry, metabolism, kinetics and biomarkers Handb Exp Pharmacol 2009 29 60
2. J.-P. Changeux Nicotine addiction and nicotinic receptors: lessons from genetically modified mice Nat Rev Neurosci 11 2010 389 401
3. K.E. Cornish, A.C. Harris, M.G. Lesage, D.E. Keyler, D. Burroughs, and C. Earley Combined active and passive immunization against nicotine: minimizing monoclonal antibody requirements using a target antibody concentration strategy Int Immunopharmacol 11 2011 1809 1815
4. L.P. Dwoskin, A.M. Smith, T.E. Wooters, Z. Zhang, P.A. Crooks, and M.T. Bardo Nicotinic receptor-based therapeutics and candidates for smoking cessation Biochem Pharmacol 78 2009 732 743
5. J.J. Escobar-Chávez, C.L. Domínguez-Delgado, and I.M. Rodríguez-Cruz Targeting nicotine addiction: the possibility of a therapeutic vaccine Drug Des Devel Ther 5 2011 211 224
6. R.E.F. Fahim, P.D. Kessler, S.A. Fuller, and M.W. Kalnik Nicotine vaccines CNS Neurol Disord Drug Targets 10 2011 905 915
7. D.K. Hatsukami, D.E. Jorenby, D. Gonzales, N.A. Rigotti, E.D. Glover, and C.A. Oncken Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic Clin Pharmacol Ther 89 2011 392 399
8. I.D. Hirschhorn, and J.A. Rosecrans Studies on the time course and the effect of cholinergic and adrenergic receptor blockers on the stimulus effect of nicotine Psychopharmacology (Berl) 40 1974 109 120
9. D.E. Keyler, S.A. Roiko, E. Benlhabib, M.G. LeSage, J.V.S. Peter, and S. Stewart Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose- and affinity-response relationships Drug Metab Dispos 33 2005 1056 1061 (Pubitemid 41002789)
10. D.E. Keyler, S.A. Roiko, C.A. Earley, M.P. Murtaugh, and P.R. Pentel Enhanced immunogenicity of a bivalent nicotine vaccine Int Immunopharmacol 8 2008 1589 1594
11. B. Le Foll, and S.R. Goldberg Nicotine as a typical drug of abuse in experimental animals and humans Psychopharmacology 184 2006 367 381 (Pubitemid 43255853)
12. C. Lerman, M.G. LeSage, K.A. Perkins, S.S. O'Malley, S.J. Siegel, and N.L. Benowitz Translational research in medication development for nicotine dependence Nat Rev Drug Discov 6 2007 746 762 (Pubitemid 47338182)
13. M.G. LeSage, D.E. Keyler, D. Shoeman, D. Raphael, G. Collins, and P.R. Pentel Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine Pharmacol Biochem Behav 72 2002 279 289 (Pubitemid 34251337)
14. M.G. LeSage, D.E. Keyler, G. Collins, and P.R. Pentel Effects of continuous nicotine infusion on nicotine self-administration in rats: relationship between continuously infused and self-administered nicotine doses and serum concentrations Psychopharmacology (Berl) 170 2003 278 286 (Pubitemid 37491607)
15. M.G. LeSage, D.E. Keyler, Y. Hieda, G. Collins, D. Burroughs, and C. Le Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats Psychopharmacology (Berl) 184 2006 409 416 (Pubitemid 43255857)
16. M.G. LeSage, D.E. Keyler, and P.R. Pentel Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies AAPS J 8 2006 E65 E75
17. M.G. LeSage, D. Shelley, J.T. Ross, F.I. Carroll, and W.A. Corrigall Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats Pharmacol Biochem Behav 91 2009 461 467
18. M.G. LeSage, J.L. Perry, C.M. Kotz, D. Shelley, and W.A. Corrigall Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA Psychopharmacology (Berl) 209 2010 203 212
19. E.D. Levin, S. Slade, C. Wells, A. Petro, and J.E. Rose D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of response Pharmacol Biochem Behav 98 2011 210 214
20. N. Lindblom, S.H. De Villiers, G. Kalayanov, S. Gordon, A.M. Johansson, and T.H. Svensson Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats Respiration 69 2002 254 260 (Pubitemid 34827841)
21. D.H. Malin, C.L. Alvarado, K.S. Woodhouse, H. Karp, E. Urdiales, and D. Lay Passive immunization against nicotine attenuates nicotine discrimination Life Sci 70 2002 2793 2798 (Pubitemid 34312012)
22. R.S. Mansbach, L.K. Chambers, and C.C. Rovetti Effects of the competitive nicotinic antagonist erysodine on behavior occasioned or maintained by nicotine: comparison with mecamylamine Psychopharmacology 148 2000 234 242 (Pubitemid 30136730)
23. A. Markou, N.E. Paterson, and S. Semenova Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation Ann N Y Acad Sci 1025 2004 491 503 (Pubitemid 39643899)
24. A.Y. Moreno, and K.D. Janda Immunopharmacotherapy: vaccination strategies as a treatment for drug abuse and dependence Pharmacol Biochem Behav 92 2009 199 205
25. A.Y. Moreno, M.R. Azar, N.A. Warren, T.J. Dickerson, G.F. Koob, and K.D. Janda A critical evaluation of a nicotine vaccine within a self-administration behavioral model Mol Pharm 7 2010 431 441
26. R.L. Papke, L.P. Dwoskin, P.A. Crooks, G. Zheng, Z. Zhang, and J.M. McIntosh Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimeras Neuropharmacology 54 2008 1189 1200
27. N.E. Paterson, W. Froestl, and A. Markou The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat Psychopharmacology 172 2004 179 186 (Pubitemid 38388767)
28. M.R. Picciotto, N.A. Addy, Y.S. Mineur, and D.H. Brunzell It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood Prog Neurobiol 84 2008 329 342
29. J.A. Pratt, I.P. Stolerman, H.S. Garcha, V. Giardini, and C. Feyerabend Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor Psychopharmacology 81 1983 54 60 (Pubitemid 13038262)
30. M. Pravetoni, D.E. Keyler, R.R. Pidiparthi, F.I. Carroll, S. Runyon, and M.P. Murtaugh Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificity Biochem Pharmacol 83 2012 543 550
31. D. Quarta, C.G. Naylor, and I.P. Stolerman The serotonin 2 C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination Psychopharmacology (Berl) 193 2007 391 402 (Pubitemid 47063518)
32. S.A. Roiko, A.C. Harris, M.G. LeSage, D.E. Keyler, and P.R. Pentel Passive immunization with a nicotine-specific monoclonal antibody decreases brain nicotine levels but does not precipitate withdrawal in nicotine-dependent rats Pharmacol Biochem Behav 93 2009 105 111
33. J.E. Rose, F.M. Behm, E.C. Westman, E.D. Levin, R.M. Stein, and G.V. Ripka Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone Clin Pharmacol Ther 56 1994 86 99 (Pubitemid 24251569)
34. J.E. Rose, F.M. Behm, and E.C. Westman Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy Exp Clin Psychopharmacol 6 1998 331 343 (Pubitemid 28393951)
35. S.D. Sanderson, S.R. Cheruku, M.P. Padmanilayam, J.L. Vennerstrom, G.M. Thiele, and M.I. Palmatier Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant Int Immunopharmacol 3 2003 137 146 (Pubitemid 36106459)
36. J.W. Smith, and I.P. Stolerman Recognising nicotine: the neurobiological basis of nicotine discrimination Handb Exp Pharmacol 2009 295 333
37. I.P. Stolerman, J.A. Pratt, H.S. Garcha, V. Giardini, and R. Kumar Nicotine cue in rats analysed with drugs acting on cholinergic and 5-hydroxytryptamine mechanisms Neuropharmacology 22 1983 1029 1037 (Pubitemid 13022930)
38. I.P. Stolerman, H.S. Garcha, J.A. Pratt, and R. Kumar Role of training dose in discrimination of nicotine and related compounds by rats Psychopharmacology 84 1984 413 419 (Pubitemid 15205971)
39. F.S. Tennant Jr., A.L. Tarver, and R.A. Rawson Clinical evaluation of mecamylamine for withdrawal from nicotine dependence NIDA Res Monogr 49 1984 239 246 (Pubitemid 15019538)
40. L.H. Wilkins Jr., A. Haubner, J.T. Ayers, P.A. Crooks, and L.P. Dwoskin N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: inhibition of S(-)-nicotine-evoked [(3)H]dopamine overflow from superfused rat striatal slices J Pharmacol Exp Ther 301 2002 1088 1096 (Pubitemid 34595101)
41. T.E. Wooters, A.M. Smith, M. Pivavarchyk, K.B. Siripurapu, J.M. McIntosh, and Z. Zhang bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse Br J Pharmacol 163 2011 346 357
42. R. Young, and R.A. Glennon Nicotine and bupropion share a similar discriminative stimulus effect Eur J Pharmacol 443 2002 113 118 (Pubitemid 34603605)
43. E.S. Zakharova, W. Danysz, and A.Y. Bespalov Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats Psychopharmacology (Berl) 179 2005 128 135 (Pubitemid 40576699)
44. M. Zaniewska, A.C. McCreary, E. Przegaliński, and M. Filip Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats Eur J Pharmacol 540 2006 96 106 (Pubitemid 43866706)